Role of microRNAs in Hepatic Stellate Cells and Hepatic Fibrosis: An Update.
Non-coding RNA
biomarkers
hepatic fibrosis
hepatic stellate cells
microRNAs
therapy.
Journal
Current pharmaceutical design
ISSN: 1873-4286
Titre abrégé: Curr Pharm Des
Pays: United Arab Emirates
ID NLM: 9602487
Informations de publication
Date de publication:
Historique:
received:
06
05
2020
accepted:
15
09
2020
pubmed:
27
10
2020
medline:
25
2
2023
entrez:
26
10
2020
Statut:
ppublish
Résumé
MicroRNAs (miRNAs) are small non-coding RNA molecules that regulate the expression of targets genes by binding to the 3'-untranslated regions. They play vital roles in diverse biological processes, including the development of hepatic fibrosis (HF). HF is characterized by the accumulation of extracellular matrix (ECM) and hepatic stellate cells (HSCs) are considered a major cell type for producing ECM. Alteration of the HSC phenotype plays a crucial role in the HF pathological process. MiRNAs involved in various biological process, such as differentiation, apoptosis, migration, and their relevant signaling pathways, are expressed in HSCs; however, emerging evidence indicates that numerous miRNAs are abnormally expressed in activated HSCs. In this review, we summarize the categorization of miRNAs in HF and describe the relationships among them. We also discuss miRNAs recently discovered to be related to HF, and attempt to find potential miRNAs that may serve as novel biomarkers for use in HF treatment.
Identifiants
pubmed: 33100194
pii: CPD-EPUB-110878
doi: 10.2174/1381612826666201023143542
doi:
Substances chimiques
MicroRNAs
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
3000-3011Subventions
Organisme : National Science Foundation of China
ID : 81970534
Informations de copyright
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.